These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1892080

  • 1. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias.
    Reimer A, Paul T, Kallfelz HC.
    Am J Cardiol; 1991 Sep 15; 68(8):741-4. PubMed ID: 1892080
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A, Kramer HH, Krogmann ON, Rammos S, Bourgeous M.
    Eur Heart J; 1994 Aug 15; 15(8):1050-6. PubMed ID: 7527342
    [Abstract] [Full Text] [Related]

  • 3. Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up.
    Guccione P, Drago F, Di Donato RM, Cicini MP, Pasquini L, Marino B, Marcelletti C, Ragonese P.
    Am Heart J; 1991 Oct 15; 122(4 Pt 1):1022-7. PubMed ID: 1927853
    [Abstract] [Full Text] [Related]

  • 4. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.
    Janousek J, Paul T.
    Am J Cardiol; 1998 May 01; 81(9):1121-4. PubMed ID: 9605053
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of propafenone in congenital junctional ectopic tachycardia.
    Paul T, Reimer A, Janousek J, Kallfelz HC.
    J Am Coll Cardiol; 1992 Oct 01; 20(4):911-4. PubMed ID: 1527301
    [Abstract] [Full Text] [Related]

  • 6. The use of propafenone in the treatment of tachyarrhythmias in children.
    Vignati G, Mauri L, Figini A.
    Eur Heart J; 1993 Apr 01; 14(4):546-50. PubMed ID: 8472721
    [Abstract] [Full Text] [Related]

  • 7. Guidelines for the use of propafenone in treating supraventricular arrhythmias.
    Kishore AG, Camm AJ.
    Drugs; 1995 Aug 01; 50(2):250-62. PubMed ID: 8521758
    [Abstract] [Full Text] [Related]

  • 8. [Propafenone efficacy in preventing supraventricular tachycardia in childhood].
    Bodegas A, Cabrera A, Sarrionaindía MJ, Idígoras G, Rumoroso JR, Pérez García P, Pastor E, Galdeano JM, Sota J, Barrenetxea JI.
    Rev Esp Cardiol; 1994 Feb 01; 47(2):86-91. PubMed ID: 8165353
    [Abstract] [Full Text] [Related]

  • 9. New antiarrhythmic drugs in pediatric use: propafenone.
    Paul T, Janousek J.
    Pediatr Cardiol; 1994 Feb 01; 15(4):190-7. PubMed ID: 7991437
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of intravenous propafenone for control of postoperative junctional ectopic tachycardia.
    Garson A, Moak JP, Smith RT, Norton JB.
    Am J Cardiol; 1987 Jun 01; 59(15):1422-4. PubMed ID: 3591702
    [No Abstract] [Full Text] [Related]

  • 11. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G.
    Monatsschr Kinderheilkd; 1985 Mar 01; 133(3):154-7. PubMed ID: 4010670
    [Abstract] [Full Text] [Related]

  • 12. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 13. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA, Kuhn RJ, McCaffrey FM.
    Ann Pharmacother; 1997 Nov 14; 31(11):1347-59. PubMed ID: 9391691
    [Abstract] [Full Text] [Related]

  • 14. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study.
    Chrysostomou C, Beerman L, Shiderly D, Berry D, Morell VO, Munoz R.
    Anesth Analg; 2008 Nov 14; 107(5):1514-22. PubMed ID: 18931208
    [Abstract] [Full Text] [Related]

  • 15. [The treatment of postoperative junctional ectopic tachycardia].
    Cabrera Duro A, Rodrigo Carbonero D, Galdeano Miranda JM, Martínez Corrales P, Pastor Menchaca E, Macua Biurrun P, Pilar Orive J.
    An Esp Pediatr; 2002 Jun 14; 56(6):505-9. PubMed ID: 12042148
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of propafenone for supraventricular arrhythmias in infants and children.
    Janousek J, Paul T, Reimer A, Kallfelz HC.
    Am J Cardiol; 1993 Aug 01; 72(3):294-300. PubMed ID: 8342507
    [Abstract] [Full Text] [Related]

  • 17. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M, Cullen MT, Casadei G.
    Eur Heart J; 1995 Dec 01; 16(12):1943-51. PubMed ID: 8682031
    [Abstract] [Full Text] [Related]

  • 18. [Effectiveness of propafenone in congenital ectopic junctional tachycardia--a case report].
    Paul T, Reimer A, Kallfelz HC.
    Z Kardiol; 1992 Sep 01; 81(9):482-5. PubMed ID: 1441700
    [Abstract] [Full Text] [Related]

  • 19. Intravenous propafenone for termination of reentrant supraventricular tachycardia. A placebo-controlled, randomized, double-blind, crossover study.
    Shen EN, Keung E, Huycke E, Dohrmann ML, Nguyen N, Morady F, Sung RJ.
    Ann Intern Med; 1986 Nov 01; 105(5):655-61. PubMed ID: 3767146
    [Abstract] [Full Text] [Related]

  • 20. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ, Anderson JL.
    Am J Cardiol; 1996 Aug 15; 78(4):430-4. PubMed ID: 8752188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.